Showing results (1211-1220 of 1,369) with videos related to

Sort By:
Pageof 137
The Journal of Biological Chemistry|June 27, 2013
Sea anemone peptide with uncommon β-hairpin structure inhibits acid-sensing ion channel 3 (ASIC3) and reveals analgesic activityDmitry I Osmakov, Sergey A Kozlov, Yaroslav A Andreev, et al.
International Journal of Molecular Sciences|July 26, 2020
Amyloidogenic Propensities of Ribosomal S1 Proteins: Bioinformatics Screening and Experimental CheckingSergei Y Grishin, Evgeniya I Deryusheva, Andrey V Machulin, et al.
The Journal of Allergy and Clinical Immunology|August 24, 2023
Longitudinal dynamics of the gut microbiome and metabolome in peanut allergy developmentYoojin Chun, Alexander Grishin, Rebecca Rose, et al.
The Journal of Organic Chemistry|October 10, 2025
1,3-Dipolar Cycloaddition of Nitrile Imines to 2-Imino-thiazolo[3,2-a]pyrimidin-3-ones: Dipole-Initiated Thiazolone-Imidazolone RearrangementJuliana V Petrova, Maria E Filkina, Yuri K Grishin, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 6, 2008
Induction of fibroblast growth factor 10 (FGF10) in the ileal crypt epithelium after massive small bowel resection suggests a role for FGF10 in gut adaptationCindy C Tai, Jennifer L Curtis, Frederic G Sala, et al.
The Journal of Biological Chemistry|January 14, 2001
An ERG channel inhibitor from the scorpion Buthus eupeusY V Korolkova, S A Kozlov, A V Lipkin, et al.
Marine Drugs|December 20, 2013
Polypeptide modulators of TRPV1 produce analgesia without hyperthermiaYaroslav A Andreev, Sergey A Kozlov, Yuliya V Korolkova, et al.
Molecules (Basel, Switzerland)|June 10, 2022
Bicyclic Isoxazoline Derivatives: Synthesis and Evaluation of Biological ActivityKseniya N Sedenkova, Kristian S Andriasov, Marina G Eremenko, et al.
International Journal of Biological Macromolecules|January 1, 2021
The protealysin operon encodes emfourin, a prototype of a novel family of protein metalloprotease inhibitorsKsenia N Chukhontseva, Igor M Berdyshev, Dina R Safina, et al.
Pharmaceuticals (Basel, Switzerland)|January 28, 2026
Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment PeriodEkaterina I Alexeeva, Tatiana M Dvoryakovskaya, Irina P Nikishina, et al.
Pageof 137